Promentis Pharmaceuticals Lands $8,787,399 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=be4c8573-5610-4bc2-8266-07963a4488b5 - Date
10/6/2016 - Company Name
Promentis Pharmaceuticals - Mailing Address
826 N. Plankinton Ave. Milwaukee, WI 53203 USA - Company Description
Promentis Pharmaceuticals, Inc. is a pharmaceutical company developing novel compounds for the treatment of schizophrenia and other central nervous system disorders. - Website
http://www.promentispharma.com - Transaction Type
Venture Equity - Transaction Amount
$8,787,399 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
